iShares Convertible Bond ETFICVT

ICVT, the iShares Convertible Bond ETF, charges 0.45% per year to track the ICE BofA US Convertible Bond Index, a benchmark that is so narrow that its constituent list looks like a municipal bond ordinance committee’s weekend project. The issuer’s AI-themed marketing pages sit a click away from the ICVT product, pairing a glossy promise of “capturing AI’s potential growth” with a portfolio whose top holdings are convertible bonds from issuers that may never mention artificial intelligence in their annual reports. The fund’s mandate is plain: replicate the index, not chase AI hype. The issuer’s global site repeats the same copy-paste line about “concentrated industry-leading research,” but the fund’s portfolio is a rules-based index tracker with no active stock picking. The fee is the only thing that scales like a tech startup’s valuation.

iShares by BlackRock is the world’s largest ETF provider, and it markets ICVT alongside AI-focussed funds, creating a visual and thematic clash between a sleek AI image of gleaming machinery and the prosaic reality of a convertible-bond index. The issuer’s UK pages remind investors that most protections provided by the UK regulatory system do not apply to these products and that compensation will not be available under the UK Financial Services Compensation Scheme in the event of default. The fund is domiciled and listed in ways that limit UK investor recourse, while the issuer’s product rail repeatedly presents AI-themed pages as adjacent to ICVT, suggesting thematic adjacency rather than operational overlap.

The ICVT fund page and issuer materials do not disclose top holdings or concentration percentages in the evidence retrieved, but the mandate is clear: track the ICE BofA US Convertible Bond Index. The index methodology is documented on the issuer’s US site, which describes the index as a rules-based measure of the US convertible bond market and notes that the index is maintained by a third-party index provider. The issuer’s UK retail site provides product-level context and disclaimers but does not add holdings data or concentration figures. The fund is listed on Nasdaq, where daily market activity can be monitored, but the evidence supplied does not include a holdings list, AUM figure, or bid-ask spread data. FINRA’s fund analyser can compute expense ratios and fee impacts, but the evidence here does not include a FINRA computation for ICVT.

If you want the fund’s latest Net Asset Value, holdings, or expense-ratio confirmation, the issuer’s official ETF centre is the first stop; SEC EDGAR will hold the fund’s registration statement and any periodic filings, but the evidence supplied does not include a specific filing link for ICVT in this file. The issuer’s UK pages repeatedly note the absence of UK regulatory protections and the limited scope of compensation, which is an important operational reality for UK-domiciled investors. The fund’s tracking method is index replication, not active management, so the portfolio’s character is set by the index rules, not by an investment team’s convictions. The issuer’s global site repeats the same AI-themed marketing lines, but ICVT’s index does not target AI issuers; it targets US convertible bonds across sectors, with a conversion feature that may or may not ever align with AI hype.

For market context, Nasdaq lists ICVT and provides price and volume data, but the evidence here does not include a snapshot of today’s NAV or intraday levels. The issuer’s UK product pages and disclaimers remain the clearest source for product context and regulatory limits. The fund’s expense ratio of 0.45% is the only fee disclosed in the evidence, and it is the clearest, verifiable cost borne by investors. The issuer’s repeated presentation of ICVT alongside AI-themed products is a marketing juxtaposition, not a representation of the fund’s holdings or strategy.